CS logo
small CS logo
Memorial Sloan Kettering Cancer Center

New York, New York, United States
Hospital in New York City, New York
1275 York Ave, New York, NY 10065
498 (2018) Beds

About Memorial Sloan Kettering Cancer Center


Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City, founded in 1884 as the New York Cancer Hospital.
There are 498 (2018) beds in Memorial Sloan Kettering Cancer Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Memorial Sloan Kettering Cancer Center


During the past decade, Memorial Sloan Kettering Cancer Center conducted 1772 clinical trials. In the 10-year time frame, 1772 clinical trials started and 857 clinical trials were completed, i.e. on average, 48.4% percent of trials that started reached the finish line to date. In the past 5 years, 750 clinical trials started and 440 clinical trials were completed. i.e. 58.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Memorial Sloan Kettering Cancer Center" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 1513 trials, followed by "National Cancer Institute (NCI)" with 288 trials sponsored, "Alliance for Clinical Trials in Oncology" with 110 trials sponsored, "Children's Oncology Group" with 97 trials sponsored and "Hoffmann-La Roche" with 97 trials sponsored. Other sponsors include 1758 different institutions and companies that sponsored additional 546 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 921 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 74 trials as a collaborator, "Weill Medical College of Cornell University" with 70 trials as a collaborator, "Bristol-Myers Squibb" with 65 trials as a collaborator and "Merck Sharp & Dohme LLC" with 62 trials as a collaborator. Other collaborators include 2420 different institutions and companies that were collaborators in the rest 839 trials.

Clinical Trials Conditions at Memorial Sloan Kettering Cancer Center


According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Cancer Center" are "Breast Cancer" (270 trials), "Prostate Cancer" (184 trials), "Lymphoma" (155 trials), "Ovarian Cancer" (133 trials) and "Lung Cancer" (131 trials). Many other conditions were trialed in "Memorial Sloan Kettering Cancer Center" in a lesser frequency.

Clinical Trials Intervention Types at Memorial Sloan Kettering Cancer Center


Most popular intervention types in "Memorial Sloan Kettering Cancer Center" are "Drug" (2641 trials), "Other" (660 trials), "Biological" (628 trials), "Procedure" (488 trials) and "Radiation" (380 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (171 trials), "Placebo" (120 trials), "Cyclophosphamide" (102 trials), "filgrastim" (92 trials) and "cyclophosphamide" (91 trials). Other intervention names were less common.

Clinical Trials Genders at Memorial Sloan Kettering Cancer Center


The vast majority of trials in "Memorial Sloan Kettering Cancer Center" are 3155 trials for "All" genders, 455 trials for "Female" genders and 224 trials for "Male" genders.

Clinical Trials Status at Memorial Sloan Kettering Cancer Center


Currently, there are NaN active trials in "Memorial Sloan Kettering Cancer Center". undefined are not yet recruiting, 709 are recruiting, 732 are Active, not recruiting, and 15 are Enrolling by invitation. In total, there were 2005 completed trials in Memorial Sloan Kettering Cancer Center, 12 suspended trials, and 260 terminated clinical trials to date.
Out of the total trials that were conducted in Memorial Sloan Kettering Cancer Center, 1180 "Phase 1" clinical trials were conducted, 1632 "Phase 2" clinical trials and 546 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 326 trials that are defined as “Not Applicable".

Departments of Memorial Sloan Kettering Cancer Center


Memorial Sloan Kettering Cancer Center has several departments that took part in Clinical trials: "Memorial Sloan Kettering Cancer Center David H Koch Center for Cancer Care" - 20 trials, "Ralph Lauren Center for Cancer Care and Prevention" - 20 trials, "Memorial Sloan-Kettering Cancer Center 53rd Street" - 11 trials, "Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center" - 6 trials, "Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy" - 4 trials, "Memorial Sloan Kettering Cancer Center; Clinical Trials Office" - 3 trials, "Memorial Sloan - Kettering Cancer Center (Consent and follow-up)" - 3 trials, "Memorial Sloan Kettering Cancer Center Hauppauge" - 3 trials, "Hartford Healthcare Cancer Alliance (Data collection only)" - 3 trials, "Memorial Sloan-Kettering Cancer Center; Hematology/Oncology" - 3 trials, "Memorial Sloan-Kettering Cancer Center SC" - 2 trials, "Memorial Sloan Kettering Cancer Center: Breast and Imaging Center" - 2 trials